Effects of a carbonic anhydrase inhibitor on cerebral blood flow in geriatric patients.

AUTOR(ES)

Wyper, D J

RESUMO

A carbonic anhydrase inhibitor (UK-12,130) was shown to increase cerebral blood flow in mildly demented geriatric patients. Oral administration caused a significant increase in blood flow at two different dose levels; this persisted for at least six weeks, which was the duration of the longest study. There was no consistent improvement in mentation during treatment. Blood blow was measured by the washout of 133Xe after inhalation of this inert gas.

Documentos Relacionados

• A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.
• Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients.
• Carbonic anhydrase isozymes IV and II in urinary membranes from carbonic anhydrase II-deficient patients.
• Cerebral blood flow, arteriovenous oxygen difference, and outcome in head injured patients.
• Hyperkalaemia induced by carbonic anhydrase inhibitor.